Atrial Appendage Occluder Market Growth, Analysis, Research and Forecast to 2032

Posted by Ganesh Shinde on April 12th, 2023

The global atrial appendage occluder market was worth US$ 854.6 million in 2022 and is predicted to grow at a spectacular double-digit CAGR of 23.95% to reach a market worth US$ 7,316.9 million between 2022 and 2032.

The growing elderly population, particularly in North America and Europe, is driving market growth. In the historical period 2016 to 2021, the market for atrial appendage occluder grew at an 8% CAGR.

The atrial appendage, also known as the left atrial appendage (LAA), is an ear-shaped pouch located in the top left chamber of the human heart (Left Atrium). This structure's functional significance is unknown. Blood accumulates in the left atrial appendage of people with arrhythmic cardiovascular disorders such as atrial fibrillation and can induce blood clotting.

As blood clots are pushed into blood vessels, they can induce a deadly stroke. Occlusion of the LAA with an occluder, in addition to oral anticoagulants, is an alternate way to protecting cardiovascular patients from strokes and other problems. Hence, an atrial appendage occluder is a type of plug that permanently seals the appendage.

According to FMI, North America would dominate the atrial appendage occluders market over the projection period. This is due to its large geriatric population.

Furthermore, the region's massive population, which accounts for the greatest number of stroke deaths, is the primary cause for people who rely on atrial appendage occluders, notably in the United States. Hence, North America is expected to have a 39.8% market share for atrial appendage occluders in 2022.

Key Companies Profiled:

  • Appriva Medical Inc.
  • Boston Scientific
  • Abbott
  • SentreHEART Inc
  • pfm medical ag.
  • Occlutech
  • W. L. Gore & Associates
  • Coherex Medical, Inc.
  • Cardia, Inc.
  • AtriCure, Inc

Browse More Details@ https://www.futuremarketinsights.com/reports/atrial-appendage-occluder-market

Key Segments Profiled In The Atrial Appendage Occluder Industry Survey

Type of indication:

  • Non-valvular Atrial Fibrillation

Procedure of positioning of the device:

  • Endocardial
  • Epicardial

End user:

  • Hospitals
  • Clinics

Like it? Share it!


Ganesh Shinde

About the Author

Ganesh Shinde
Joined: October 27th, 2022
Articles Posted: 868

More by this author